BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
NCT01290406
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
BEZ235
Sponsor
Novartis Pharmaceuticals